Alector (ALEC) Change in Account Payables (2018 - 2026)
Alector's (ALEC) quarterly Change in Account Payables came in at -$268000.0 in Q1 2026, down 341.44% year-on-year from $111000.0 in Q1 2025, and up 91.26% on a QoQ basis from -$3.1 million in Q4 2025.
Alector (ALEC) Change in Account Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Change in Account Payables data on file, last reported at -$268000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 341.44% year-over-year to -$268000.0 in Q1 2026; TTM through Mar 2026 was -$903000.0, a 59.83% increase from a year earlier, with the FY2025 full-year figure at -$524000.0, up 63.64% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$268000.0, up from -$3.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for ALEC reached as high as $2.5 million in Q3 2025 and fell as low as -$3.1 million in Q4 2025.
- Historically, Change in Account Payables has averaged -$187176.5 across 5 years, with a median of -$109000.0 in 2025.
- Across the five-year window, Change in Account Payables sank 437.04% in 2023 and jumped 17150.0% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at -$189000.0 in 2022, then sank by 437.04% to -$1.0 million in 2023, then plunged by 173.3% to -$2.8 million in 2024, then declined by 10.53% to -$3.1 million in 2025, then jumped by 91.26% to -$268000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$268000.0 in Q1 2026, -$3.1 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | -268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | -109,000.00 |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 690,000.00 |
| Sep 30, 2024 | 690,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Dec 31, 2023 | -1.02 Mn |
| Dec 31, 2023 | -1.02 Mn |